Skip to content

Gross margin at other companies

Rogers Corporation logo
Rogers CorporationROG
32.2%-0.7pp
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
90%+2.5pp
BridgeBio Pharma logo
BridgeBio PharmaBBIO
95.1%-0.2pp
Kiniksa Pharmaceuticals International, plc logo
Kiniksa Pharmaceuticals International, plcKNSA
89.3%+3.5pp
LQD
Liquidia CorporationLQDA
58.1%-18.7pp
ALN
Alnylam PharmaceuticalsALNY
81%-5.3pp

Other financials

Income statement

See full
Revenue$77.7M+24.4%
Gross profit$71.2M+32.1%
Operating income$41.4M+89.6%
Net income$34.4M+47.2%
EPS (diluted)$0.25+56.3%

Balance sheet

See full
Cash & equivalents$41.0M-38.3%
Total debt$85.2M-7.9%
Total equity$567.6M+62.1%
Total assets$724.0M+43.4%

Cash flow

See full
Operating cash flow$32.6M+2,405%

Valuation

See full
Market cap$2.3B+78.5%
Enterprise value$2.34B+78.3%
P/E7.7×-24.6×
P/S7.7×+2.5×

Profitability

See full
Operating margin41.7%+29.4pp
Net margin100%+83.9pp

Returns & leverage

See full
Return on equity65%+53.8pp
Debt / equity0.2×-0.1×
Current ratio5.5×-0.4×

Where this comes from

Calculated from Aurinia Pharmaceuticals’s reported figures.

Based on trailing twelve months.

The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aurinia Pharmaceuticals's gross margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aurinia Pharmaceuticals's gross margin?
Aurinia Pharmaceuticals (AUPH) reported gross margin of 89.7% in Q1 2026.
How has Aurinia Pharmaceuticals's gross margin changed year-over-year?
Aurinia Pharmaceuticals's gross margin increased by 1.7% year-over-year, from 88.2% to 89.7%.
What is the long-term trend for Aurinia Pharmaceuticals's gross margin?
Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's gross margin has grown at a -2.4% compound annual growth rate (CAGR), from 100% to 88.5%.
What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.